Novel Treatments for Battlefield Injuries and Scars

Supporting Human Studies Of Novel Treatments For Battlefield Injuries And Scars 05/29/2010. A two-year, $12 million contract with the U.S. Department of Defense Office of Technology Transition (OTT) will jumpstart human trials of three innovative research programs that aim to replace scars and defects with healthy, functional tissues, announced officials of the University of Pittsburgh and the McGowan Institute for Regenerative Medicine today at the Institute's Second Annual Open Session, Soldiers and Sailors Memorial Hall, Oakland.   University of Pittsburgh Schools of the Health Sciences via Medical News Today